Login
$PVLA
$144.90 +$0.30 (0.21%) After hours

$PVLA 8-K/A SEC Filings

Filed On Filing
31 Aug 2023 8-K/A: Costs Associated with Exit or Disposal Activities

On August 30, 2023, the Compensation and Management Development Committee of the Board of Directors of the Company approved retention benefits for retained employees (other than executive officers) in connection with the Workplace Restru...

12 May 2022 8-K/A: Regulation FD Disclosure

PIERIS PHARMACEUTICALS SUPERIOR MEDICINES THROUGH EFFICIENT BIOLOGY CORPORATE PRESENTATION May 2022

14 Jan 2022 8-K/A: Regulation FD Disclosure

Attached hereto as Exhibit 99.1 and incorporated by reference herein is the November 2021 Investor Presentation of Pieris Pharmaceuticals, Inc.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support